Skip to main content

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Recruiting · Phase 2 · NCT06143956

Conditions: Obesity, Overweight

At a glance

Research payments reported, 2025
$4.0M
U.S. investigators named
53
Sites paid
60
Planned or actual enrollment
1,481

About the trial

Sponsor
Eli Lilly and Company
Tested
LY3305677 (drug), LY3841136 (drug), Tirzepatide (drug), LY3549492 (drug), LY3532226 (drug), Placebo (drug), Placebo (drug)
Dates
Started 2023-11-17; completion 2028-02
Results posted
Not yet

The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The CWMM establishes entry criteria for newly enrolled participants across the master and the ISAs. The ISAs may start independently of other ISAs as interventions become available for clinical testing. The results for the CWMM screening record will be reported when all the ISA's complete.

From ClinicalTrials.gov, last updated 2026-10-07. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $4.0M in research payments for this study in 2025 (166 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Charter Research LLC $569,149
  • Monroe Biomedical Research $481,370
  • Indago Research & Health Center Inc $222,167
  • Headlands Horizons LLC $201,415
  • Great Lakes Clinical Trials $191,707
  • Velocity Clinical Research Inc $178,351
  • Institute for Liver Health LLC $161,705
  • New Horizon Research Center $157,629
  • Lucas Research Inc $142,086
  • Clinvest Headlands LLC $120,015
  • Texas Valley Clinical Research LLC $117,773
  • Las Vegas Medical Research LLC $110,988
  • Erg Holding Co LLC DBA St Louis Clinical Trials LLC $101,710
  • Ima Evaluations LLC DBA Ima Clinical Research $97,480
  • Peninsula Headlands LLC $92,843
  • Studymetrix Research LLC $77,698
  • Endocrine Ips PLLC $75,541
  • Stamford Therapeutics Consortium $67,536
  • Sociedad Espanola De Medicina De La Adolescencia $67,201
  • Ascension Medical Group $58,446
  • Medical Research PArtners $55,760
  • Iowa Diabetes and Endocrinology Rsrch Cntr $55,461
  • Danville Orthopedic Clinic Inc $49,949
  • Arcturus Healthcare PLC, Troy Internal $40,466
  • Cti Holdings Inc DBA Community Research Management Associates Inc $40,068
  • Norcal Medical Research Inc $37,847
  • Medication Management LLC $36,184
  • Central Washington Health Services $35,652
  • Rochester Clinical Research Inc $32,768
  • Lucida Clinical Trials $31,359
  • Suncoast Clinical Research $31,160
  • True North Med at N Suffolk Pplc $30,310
  • Tekton Research Inc $29,623
  • Seen Medical of Ma PC DBA Knownwell $27,525
  • Dent Neurosciences Research Center Inc $27,169
  • Tribe Clinical Research LLC $23,652
  • Northeast Research Institute $20,078
  • Hope Research Institute LLC $18,575
  • Louisville Metabolic $17,559
  • Cotton Oneil Msd of Stormont Vail Healthcare $16,246
  • Future Search Trials of Dallas LP $14,826
  • Northshore University Healthsystem - Evanston Hospital, IL $11,539
  • Diabetes and Endocrinology Consultants $5,413
  • Clinvest Research LLC $4,670
  • Knownwell $4,118
  • Medex Healthcare Research Inc $4,017
  • Endeavor Clinical Trials PA $3,110
  • Cahaba Research $2,528
  • Palos Verdes Medical Group $2,356
  • Futuresearch Trials of Neurology LP $2,238
  • Wenatchee Valley Hospital $1,899
  • University at Buffalo $1,892
  • Yshay Shlesinger MD $1,391
  • North Suffolk Neurology $1,331
  • Kerwin Memory Center LLC $794
  • Andrew J Lewin Med DBA National Rsrch Institute $542
  • Dallas Diabetes and Endo Research Center PA $472
  • Pharmquest LLC $393
  • Mountain View Clinical Research Inc $130
  • $9
  • Pacific Diabetes and Endocrine Center $2

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.